Terminated NA INTERVENTIONAL NCT00204230

MMF and Calcineurin Inhibitor Withdrawal in CAN

Randomized Controlled Study: Effect of Mycophenolatmofetil in Patients With Histologically Proven Chronic Allograft Nephropathy

Sponsor: Hoffmann-La Roche

Conditions Immunosuppressive Agents Kidney Failure, Chronic Kidney Transplantation

Interventions mycophenolate mofetil (drug)

Updated 4 times since 2017 Last updated: Sep 12, 2005 Started: Oct 31, 1999 Completion: Sep 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Hoffmann-La Roche

See all terminations from Hoffmann-La Roche

Listed as NCT00204230, this NA trial focuses on Immunosuppressive Agents and Kidney Failure, Chronic and remains terminated or withdrawn. Sponsored by Hoffmann-La Roche, it has been updated 4 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jan 2017 — Jan 2021 [monthly]

Terminated NA

First recorded

Oct 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoffmann-La Roche
University Hospital Muenster

Data source: University Hospital Muenster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.